Sinopharm Group Co. Ltd. (SHTDY)

Market Cap	6.15B -18.0%
Revenue (ttm)	84.20B -0.7%
Net Income	1.04B +4.1%
EPS	0.33 +4.0%
Shares Out	n/a
PE Ratio	5.89
Forward PE	5.35
Dividend	0.38 (3.93%)
Ex-Dividend Date	Jun 24, 2026

Volume	470
Open	9.83
Previous Close	9.73
Day's Range	9.82 - 9.83
52-Week Range	9.73 - 14.87
Beta	0.45
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About Sinopharm Group

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People’s Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2003
• Employees: 90,447
• Stock Exchange: OTCMKTS
• Ticker Symbol: SHTDY

Financial Performance

In 2025, Sinopharm Group's revenue was 575.17 billion, a decrease of -1.60% compared to the previous year's 584.51 billion. Earnings were 7.16 billion, an increase of 1.50%.

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 3, 2026

Data Sources Report a data error